Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial-Reference-Cited by-同舟云学术

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

Published:2009-10 Issue:9696 Volume:374 Page:1149-1159
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Mehran Roxana,Lansky Alexandra J,Witzenbichler Bernhard,Guagliumi Giulio,Peruga Jan Z,Brodie Bruce R,Dudek Dariusz,Kornowski Ran,Hartmann Franz,Gersh Bernard J,Pocock Stuart J,Wong S Chiu,Nikolsky Eugenia,Gambone Louise,Vandertie Lynn,Parise Helen,Dangas George D,Stone Gregg W

Publisher

Elsevier BV

Subject

General Medicine

Reference37 articles.

1. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction;Stone;N Engl J Med,2002

2. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials;Kandzari;Am Heart J,2004

3. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction;Montalescot;N Engl J Med,2001

4. Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade;Kereiakes;Am Heart J,2000

5. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting;Merlini;Circulation,2004

Cited by 360 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antithrombotic Therapy in Patients with Complex Percutaneous Coronary Intervention and Cardiogenic Shock;Interventional Cardiology Clinics;2024-10

2. Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis;American Journal of Cardiovascular Drugs;2024-04-29

3. Crystal structure of tick tyrosylprotein sulfotransferase reveals the activation mechanism of the tick anticoagulant protein madanin;Journal of Biological Chemistry;2024-03

4. Impact of Bivalirudin on Ischemia/Reperfusion Injury in Patients with Reperfused STEMI Assessed by Cardiac Magnetic Resonance;Pharmaceuticals;2024-02-01

5. Letter to the editor: 1-year clinical outcomes of bivalirudin vs. unfractionated heparin in patients with type 2 diabetes undergoing elective percutaneous coronary intervention;European Heart Journal - Cardiovascular Pharmacotherapy;2024-01-29